心血管系统疾病（临床处方审核案例详解丛书）最新章节_刘春霞著

参考文献

［1］葛均波, 徐永健, 王辰. 内科学 [M]. 9版. 北京: 人民卫生出版社, 2018.

［2］王辰, 王建安. 内科学 (上、下册)[M]. 3版. 北京: 人民卫生出版社, 2015.

［3］陈灏珠. 实用心脏病学 [M]. 5版. 上海: 上海科学技术出版社, 2016.

［4］胡盛寿, 高润霖, 刘力生, 等.《中国心血管病报告2018》概要 [J]. 中国循环杂志, 2019,34 (3): 209-220.

［5］ ARNETT D K, BLUMENTHAL R S, ALBERT M A, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines [J]. Journal of the American college of cardiology, 2019, 74 (10): e177-e232.

［6］中国心血管病预防指南 (2017) 写作组, 中华心血管病杂志编辑委员会. 中国心血管病预防指南 (2017)[J]. 中华心血管病杂志, 2018, 46 (1): 10-25.

［7］中国心血管病风险评估和管理指南编写联合委员会. 中国心血管病风险评估和管理指南 [J]. 中华预防医学杂志, 2019, 53 (1): 13-35.

［8］中国营养学会. 中国居民膳食指南 (2016)[M]. 北京: 人民卫生出版社, 2016.

［9］中华医学会糖尿病学分会. 中国2型糖尿病防治指南 (2017年版)[J]. 中国实用内科杂志, 2018, 38 (04): 34-86.

［10］中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南 (2016年修订版)[J]. 中国循环杂志, 2016, 31(10): 937-953.

［11］ GRUNDY S M, STONE N J, BAILEY A L, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines [J]. Circulation,2019, 139 (25): e1046-e1081.

［12］中国高血压防治指南修订委员会, 高血压联盟 (中国), 中华医学会心血管病学分会,等. 中国高血压防治指南 (2018年修订版)[J]. 中国心血管杂志, 2019, 24 (1): 24-56.

［13］ ZHENG S L, RODDICK A J. Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and metaanalysis [J]. JAMA, 2019, 321 (3): 277-287.

［14］ GAZIANO J M, BROTONS C, COPPOLECCHIA R, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (arrive): a randomised, double-blind, placebo-controlled trial [J]. The lancet, 2018, 392（10152）:1036-1046.

［15］ BOWMAN L, MAFHAM M, WALLENDSZUS K, et al. Effects of aspirin for primary prevention in persons with diabetes mellitus [J]. The New England Journal of Medicine, 2018, 379: 1529-1539.

［16］ MCNEIL J J, WOODS R L, NELSON M R, et al. Effect of aspirin on disability-free survival in the healthy elderly [J]. The New England Journal of Medicine, 2018, 379:1499-1508.

［17］ MCNEIL J J, NELSON M R, WOODS R L, et al. Effect of aspirin on all-cause mortality in the healthy elderly [J]. The New England Journal of Medicine, 2018, 379: 1519-1528.

［18］ MCNEIL J J, WOLFE R, WOODS R L, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly [J]. The New England Journal of Medicine, 2018,379: 1509-1518.

［19］ NCD RISHK FACTOR COLLABORATION. Worldwide trends in body-mass index,underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults [J]. Lancet, 2017, 390 (10113): 2627-2642.

［20］ GUTHOLD R, STEVENS G A, RILEY L M, et al. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants [J]. The lancet global health, 2018, 6 (10): e1077-e1086.

［21］ WANG ZW, CHEN Z, ZHANG LF, et al. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015 [J]. Circulation, 2018, 137 (22): 2344-2356.

［22］ DONG Y H, JAN C, MA Y H, et al. Economic development and the nutritional status of Chinese school-aged children and adolescents from 1995 to 2014: an analysis of five successive national surveys [J]. The lancet diabetes & endocrinol, 2019, 7 (4): 288-299.